SCHEMBL13870921

SCHEMBL13870921

COc1cc2ccc(-c3cccc(C)c3)nc2cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.54
ALDH1A1 P00352 4/20 0.54
KDM4E B2RXH2 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
HSD17B10 Q99714 3/20 0.48
TSHR P16473 2/20 0.48
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HPGD P15428 3/20 0.47
TP53 P04637 3/20 0.47
LMNA P02545 2/20 0.47
MEN1 O00255 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
KMT2A Q03164 1/20 0.47
RELA Q04206 1/20 0.47
PDGFRB P09619 5/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16487825 0.86 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL13870922 0.85 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL13870935 0.84 PDGFRB (0.61) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL8501511 0.84 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL28596277 0.83 SMN1; SMN2 (0.66) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL29501311 0.83 SMN1; SMN2 (0.66) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL13870889 0.82 BCHE (0.44) SMN1; SMN2KDM4ENPC1RAB9APDGFRB
SCHEMBL1989333 0.82 KDM4E (0.51) SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL30486824 0.82 CYP1A2 (0.52) ALDH1A1KDM4ENPC1RAB9ANQO2
SCHEMBL4859835 0.82 CYP1A2 (0.52) ALDH1A1KDM4ENPC1RAB9ANQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 SMN1; SMN2 4169/4885ALDH1A1 111/4885KDM4E 2874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.